A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension

Trial Profile

A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jun 2015

At a glance

  • Drugs Bimatoprost (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Therapeutic Use
  • Sponsors ForSight VISION5
  • Most Recent Events

    • 11 Jun 2015 According to a ForSight VISION5 media release, data from this trial were presented at the World Glaucoma Congress.
    • 16 Dec 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 08 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top